On the other hand, high SOX2 and AGR2 expression with high serum level of serum AGR2 may predict a subset of breast cancer patients that are less likely to show adequate tumor growth control or recurrence following tamoxifen therapy. This evidence concerns the gene AGR2 and neoplasm.